Kim-Hafken Tina
General Counsel bei RAIN ONCOLOGY INC.
Profil
Kim-Hafken Tina is currently working as Vice President-Regulatory Affairs at Rain Oncology, Inc. Previously, she worked as Senior Director-Regulatory Affairs at Seagen Inc. She completed her undergraduate degree from The Johns Hopkins University and the University of Kansas.
Aktive Positionen von Kim-Hafken Tina
Unternehmen | Position | Beginn |
---|---|---|
RAIN ONCOLOGY INC. | General Counsel | - |
Ehemalige bekannte Positionen von Kim-Hafken Tina
Unternehmen | Position | Ende |
---|---|---|
SEAGEN INC. | General Counsel | - |
Ausbildung von Kim-Hafken Tina
The Johns Hopkins University | Undergraduate Degree |
University of Kansas | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Rain Oncology, Inc.
Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |